aspirin has been researched along with 5-hydroxy-6,8,11,14-eicosatetraenoic acid in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gryglewski, RJ; Marcinkiewicz, E; Michalska, Z; Nizankowska, E; Radomski, M; Szczeklik, A; Wandzilak, M | 1 |
Bailey, JM; Bryant, RW; Fletcher-Cieutat, M; Vanderhoek, JY | 1 |
Branch, DW; Edwin, SS; Mitchell, MD; Munoz, H; Romero, RJ | 1 |
Dalsgaard, CJ; Haegerstrand, A; Martinsson, T | 1 |
Blair, IA; Jian, W; Lee, SH; Williams, MV | 1 |
Chiamvimonvat, N; Hammock, BD; Hwang, SH; Inceoglu, B; Liu, JY; Qiu, H; Ulu, A; Yang, J | 1 |
6 other study(ies) available for aspirin and 5-hydroxy-6,8,11,14-eicosatetraenoic acid
Article | Year |
---|---|
An abnormality of arachidonic acid metabolism is not a generalized phenomenon in patients with aspirin-induced asthma.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adult; Arachidonate 12-Lipoxygenase; Arachidonic Acids; Aspirin; Asthma; Blood Platelets; Female; Humans; Hydroxyeicosatetraenoic Acids; Leukocytes; Leukotriene B4; Male; Middle Aged | 1988 |
Aspirin enhances the sensitivity of human platelet 12-lipoxygenase to inhibition by 15-HETE, an endogenous regulator.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Arachidonate Lipoxygenases; Aspirin; Blood Platelets; Drug Synergism; Humans; Hydroxyeicosatetraenoic Acids; Lipoxygenase Inhibitors | 1985 |
5-Hydroxyeicosatetraenoic acid and human parturition.
Topics: Amniocentesis; Amnion; Amniotic Fluid; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cells, Cultured; Dinoprostone; Female; Humans; Hydroxyeicosatetraenoic Acids; Interleukin-1; Labor, Obstetric; Pregnancy | 1996 |
Effects of ropivacaine on eicosanoid release from human granulocytes and endothelial cells in vitro.
Topics: 6-Ketoprostaglandin F1 alpha; Amides; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cells, Cultured; Eicosanoids; Endothelium, Vascular; Granulocytes; Humans; Hydrocortisone; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lidocaine; Mesalamine; Ropivacaine; Thrombin; Zymosan | 1997 |
5-Lipoxygenase-mediated endogenous DNA damage.
Topics: 5-Lipoxygenase-Activating Proteins; Arachidonate 5-Lipoxygenase; Aspirin; Calcimycin; Carrier Proteins; Cell Line; Cyclooxygenase 1; DNA Adducts; DNA Damage; Humans; Hydroxyeicosatetraenoic Acids; Ionophores; Leukotriene B4; Lipid Peroxidation; Lymphocytes; Membrane Proteins; Models, Biological; Prostaglandins | 2009 |
Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Aspirin; Benzoates; Blood Pressure; Dose-Response Relationship, Drug; Enzyme Activation; Epoxide Hydrolases; Gene Expression Regulation, Enzymologic; Hydroxyeicosatetraenoic Acids; Indoles; Inflammation; Lipopolysaccharides; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Prostaglandin-Endoperoxide Synthases; Urea | 2010 |